Cue Biopharma, Inc. (CUE) SEC filings
CUE SEC filings moved a median of -1.23% by the close. CUE SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the CUE overview →
82 measured CUE SEC filing events.
Where these CUE SEC filings landedvs 80 measured CUE SEC filing reactions
| Middle 50% of CUE SEC filing reactions | -5.41% to +2.33% |
|---|---|
| Median reaction (to close) | -1.23% |
| Measured reactions | 80 |
Point-in-time · zero look-ahead
Half of the 80 CUE SEC filing events with a measured close landed between -5.41% and +2.33%; 45% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K Cue Biopharma, Inc. For: Sep 20 | SEC filing · Form 8-K | -0.91% | -26.57% | |
| Form EFFECT Cue Biopharma, Inc. | SEC filing · Form EFFECT | +1.76% | -6.14% | |
| Form 10-Q Cue Biopharma, Inc. For: Jun 30 | SEC filing · Form 10-Q | +5.60% | -11.27% | |
| Form 8-K Cue Biopharma, Inc. For: Aug 14 | SEC filing · Form 8-K | +5.60% | -11.27% | |
| Form S-3 Cue Biopharma, Inc. | SEC filing · Form S-3 | -3.06% | +5.71% | |
| Form 8-K Cue Biopharma, Inc. For: Jul 27 | SEC filing · Form 8-K | +0.07% | -1.19% | |
| Form D Cue Biopharma, Inc. | SEC filing · Form D | — | +1.45% | |
| Form 8-K Cue Biopharma, Inc. For: Jul 09 | SEC filing · Form 8-K | -1.22% | -12.97% | |
| Form EFFECT Cue Biopharma, Inc. | SEC filing · Form EFFECT | +0.00% | -2.55% | |
| Form EFFECT Cue Biopharma, Inc. | SEC filing · Form EFFECT | +5.63% | +8.25% | |
| Form S-3 Cue Biopharma, Inc. | SEC filing · Form S-3 | -2.94% | +10.86% | |
| Form 8-K Cue Biopharma, Inc. For: Jun 01 | SEC filing · Form 8-K | +0.50% | +9.78% | |
| Form S-3 Cue Biopharma, Inc. | SEC filing · Form S-3 | +0.50% | +9.78% | |
| Form S-8 Cue Biopharma, Inc. | SEC filing · Form S-8 | +0.50% | +9.78% | |
| Form 8-K Cue Biopharma, Inc. For: May 29 | SEC filing · Form 8-K | +2.30% | -3.31% | |
| Form DEF 14A Cue Biopharma, Inc. For: Jun 01 | SEC filing · Form DEF | -5.44% | +1.31% | |
| Form 10-Q Cue Biopharma, Inc. For: Mar 31 | SEC filing · Form 10-Q | +1.24% | -1.29% | |
| Form 8-K Cue Biopharma, Inc. For: May 14 | SEC filing · Form 8-K | +1.24% | -1.29% | |
| Form D Cue Biopharma, Inc. | SEC filing · Form D | +1.24% | -1.29% | |
| Form PRE 14A Cue Biopharma, Inc. For: Jun 01 | SEC filing · Form PRE | -2.15% | -4.88% | |
| Form 8-K Cue Biopharma, Inc. For: Apr 27 | SEC filing · Form 8-K | +2.49% | +12.31% | |
| Form S-8 Cue Biopharma, Inc. | SEC filing · Form S-8 | -3.65% | +8.22% | |
| Form 8-K Cue Biopharma, Inc. For: Apr 22 | SEC filing · Form 8-K | +9.22% | +16.02% | |
| Form 8-K Cue Biopharma, Inc. For: Apr 13 | SEC filing · Form 8-K | +7.72% | +12.34% | |
| Form 8-K Cue Biopharma, Inc. For: Apr 01 | SEC filing · Form 8-K | +0.16% | +2.06% | |
| Form EFFECT Cue Biopharma, Inc. | SEC filing · Form EFFECT | -3.42% | -10.07% | |
| Form 8-K Cue Biopharma, Inc. For: Mar 23 | SEC filing · Form 8-K | +0.58% | +0.44% | |
| Form DEFA14A Cue Biopharma, Inc. | SEC filing · Form DEFA14A | +0.58% | +0.44% | |
| Form S-3 Cue Biopharma, Inc. | SEC filing · Form S-3 | -0.66% | -5.40% | |
| Form 10-K Cue Biopharma, Inc. For: Dec 31 | SEC filing · Form 10-K | -3.06% | -8.59% | |
| Form 8-K Cue Biopharma, Inc. For: Mar 16 | SEC filing · Form 8-K | -3.06% | -8.59% | |
| Form ARS Cue Biopharma, Inc. For: Dec 31 | SEC filing · Form ARS | -3.06% | -8.59% | |
| Form DEF 14A Cue Biopharma, Inc. For: Mar 16 | SEC filing · Form DEF | -3.06% | -8.59% | |
| Form PRE 14A Cue Biopharma, Inc. For: Mar 06 | SEC filing · Form PRE | +1.84% | +4.41% | |
| Form 8-K Cue Biopharma, Inc. For: Feb 18 | SEC filing · Form 8-K | -1.92% | -3.20% | |
| Form 8-K Cue Biopharma, Inc. For: Feb 09 | SEC filing · Form 8-K | -4.29% | -14.29% | |
| Form 8-K Cue Biopharma, Inc. For: Dec 19 | SEC filing · Form 8-K | -2.93% | -6.07% | |
| Form 8-K Cue Biopharma, Inc. For: Nov 24 | SEC filing · Form 8-K | -2.11% | +1.34% | |
| Form 8-K Cue Biopharma, Inc. For: Nov 17 | SEC filing · Form 8-K | +1.30% | +10.19% | |
| Form 10-Q Cue Biopharma, Inc. For: Sep 30 | SEC filing · Form 10-Q | -3.88% | — | |
| Form 8-K Cue Biopharma, Inc. For: Nov 12 | SEC filing · Form 8-K | -3.88% | — | |
| Form 8-K Cue Biopharma, Inc. For: Nov 06 | SEC filing · Form 8-K | -1.02% | -4.55% | |
| Form 8-K Cue Biopharma, Inc. For: Sep 26 | SEC filing · Form 8-K | +0.00% | +2.67% | |
| Form 10-Q Cue Biopharma, Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.17% | +0.04% | |
| Form 8-K Cue Biopharma, Inc. For: Aug 12 | SEC filing · Form 8-K | +0.17% | +0.04% | |
| Form S-8 Cue Biopharma, Inc. | SEC filing · Form S-8 | +0.17% | +0.04% | |
| Form 8-K Cue Biopharma, Inc. For: Jun 30 | SEC filing · Form 8-K | -3.84% | +2.22% | |
| Form 8-K Cue Biopharma, Inc. For: Jun 04 | SEC filing · Form 8-K | +1.27% | +1.75% | |
| Form DEFA14A Cue Biopharma, Inc. | SEC filing · Form DEFA14A | +2.43% | +1.86% | |
| Form 10-Q Cue Biopharma, Inc. For: Mar 31 | SEC filing · Form 10-Q | -1.15% | +5.19% | |
| Form 8-K Cue Biopharma, Inc. For: May 12 | SEC filing · Form 8-K | -1.15% | +5.19% | |
| Form ARS Cue Biopharma, Inc. For: Dec 31 | SEC filing · Form ARS | +0.96% | -1.24% | |
| Form DEF 14A Cue Biopharma, Inc. For: Jun 03 | SEC filing · Form DEF | +0.96% | -1.24% | |
| Form DEFA14A Cue Biopharma, Inc. | SEC filing · Form DEFA14A | +0.96% | -1.24% | |
| Form 8-K Cue Biopharma, Inc. For: Apr 14 | SEC filing · Form 8-K | -5.13% | -0.13% | |
| Form 8-K Cue Biopharma, Inc. For: Apr 10 | SEC filing · Form 8-K | -9.52% | -4.76% | |
| Form PRE 14A Cue Biopharma, Inc. For: Apr 14 | SEC filing · Form PRE | -9.52% | -4.76% | |
| Form 10-K Cue Biopharma, Inc. For: Dec 31 | SEC filing · Form 10-K | +0.00% | -17.58% | |
| Form 8-K Cue Biopharma, Inc. For: Mar 31 | SEC filing · Form 8-K | +0.00% | -17.58% | |
| Form S-8 Cue Biopharma, Inc. | SEC filing · Form S-8 | +0.00% | -17.58% | |
| Form 8-K Cue Biopharma, Inc. For: Mar 10 | SEC filing · Form 8-K | +1.94% | -5.44% | |
| Form 10-Q Cue Biopharma, Inc. For: Sep 30 | SEC filing · Form 10-Q | +2.67% | -17.00% | |
| Form 8-K Cue Biopharma, Inc. For: Nov 14 | SEC filing · Form 8-K | +2.67% | -17.00% | |
| Form 8-K Cue Biopharma, Inc. For: Oct 08 | SEC filing · Form 8-K | -37.81% | +1.26% | |
| Form 8-K Cue Biopharma, Inc. For: Oct 02 | SEC filing · Form 8-K | +3.36% | +16.39% | |
| Form 8-K Cue Biopharma, Inc. For: Sep 26 | SEC filing · Form 8-K | +5.15% | +11.35% | |
| Form DEF 14A Cue Biopharma, Inc. For: Oct 08 | SEC filing · Form DEF | +3.84% | +5.25% | |
| Form 8-K Cue Biopharma, Inc. For: Aug 28 | SEC filing · Form 8-K | +3.27% | +3.56% | |
| Form PRE 14A Cue Biopharma, Inc. For: Oct 08 | SEC filing · Form PRE | -5.33% | -3.87% | |
| Form 8-K Cue Biopharma, Inc. For: Aug 15 | SEC filing · Form 8-K | +1.42% | +13.43% | |
| Form 10-Q Cue Biopharma, Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.32% | -3.90% | |
| Form 8-K Cue Biopharma, Inc. For: Jul 24 | SEC filing · Form 8-K | +0.28% | -4.42% | |
| Form 8-K Cue Biopharma, Inc. For: Jun 05 | SEC filing · Form 8-K | +0.99% | -4.64% | |
| Form DEFA14A Cue Biopharma, Inc. | SEC filing · Form DEFA14A | +0.61% | -1.22% | |
| Form 10-Q Cue Biopharma, Inc. For: Mar 31 | SEC filing · Form 10-Q | -0.52% | -9.85% | |
| Form 8-K Cue Biopharma, Inc. For: May 09 | SEC filing · Form 8-K | -0.52% | -9.85% | |
| Form ARS Cue Biopharma, Inc. For: Dec 31 | SEC filing · Form ARS | +0.00% | +0.74% | |
| Form DEF 14A Cue Biopharma, Inc. For: Jun 05 | SEC filing · Form DEF | +1.80% | +2.16% | |
| Form DEFA14A Cue Biopharma, Inc. | SEC filing · Form DEFA14A | +0.33% | +0.74% | |
| Form 10-K Cue Biopharma, Inc. For: Dec 31 | SEC filing · Form 10-K | -2.59% | -1.55% | |
| Form S-8 Cue Biopharma, Inc. | SEC filing · Form S-8 | -2.59% | -1.55% | |
| Form 10-Q Cue Biopharma, Inc. For: Sep 30 | SEC filing · Form 10-Q | +3.13% | -0.39% |
Keep exploring
More CUE: earnings → · analyst actions → · CUE overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Nevro Corp. (NVRO) | 253 | 0.00% | 49% |
| DarioHealth Corp. (DRIO) | 252 | 0.00% | 45% |
| DOVA PHARMACEUTICALS (DOVA) | 251 | -0.10% | 46% |
| Krystal Biotech, Inc. (KRYS) | 251 | +0.05% | 52% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.